Seborrheic Dermatitis Treatment Market by Forecast Revenue, Trends, Share, Demand by 2030

0
497

Market Highlights

According to MRFR analysis, Seborrheic Dermatitis Treatment Market Size is expected to register a CAGR of 10.5 % during the forecast period of 2022 to 2028 and was valued at USD 3.28 Billion by 2028.

Seborrheic dermatitis is a common skin disease that causes redness, scaly patches, and dandruff. It mainly affects the scalp, but it can also occur in other oily areas of the body, such as the upper chest, face, and back. The exact cause of seborrheic dermatitis is not yet fully understood. It is a long-term skin condition that requires constant treatment. Around 25% of people in the US are suffering from seborrheic dermatitis issues. According to a Japanese study, approximately 298 people were suffering from various seborrheic dermatitis in 2018. The growth of the global seborrheic dermatitis treatment market is impacted because of multiple factors including the increasing global geriatric population, rising prevalence of skin disorder, and subpar hygiene conditions. However, the high cost of treatment is expected to curb the growth of the global seborrheic dermatitis treatment market.

The global seborrheic dermatitis treatment market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Key Players

Some of the key players in the Global Seborrheic Dermatitis Treatment Market are Sonoma Pharmaceuticals (US), Merck (US), Hikma Pharmaceuticals (UK), Allen and Hanburys (UK), GlaxoSmithKline (UK), Bausch Health (Canada), Valent Pharmaceutical (UK), and West-Ward Pharmaceutical Corp. (US).

Segmentation

The global Seborrheic Dermatitis Treatment Market has been segmented based on treatment type, route of administration, and end user.

The market, based on treatment type, has been divided into antifungal products, corticosteroid lotions, and sulfur products. Around 1.5 million Americans are diagnosed with various seborrheic dermatitis every year. The corticosteroid lotions segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the pediatric population. 

The global seborrheic dermatitis treatment market has been segmented, on the basis of route of administration, oral, and topical. The oral segment is expected to hold the majority share of the market. Around 25 million adults are diagnosed with chronic seborrheic dermatitis every year, and most of them treated with the help of oral drugs. The topical segment is expected to be the fastest-growing due to its increasing use globally. It was estimated that around 1.3 million people in the US were afflicted with seborrheic dermatitis in 2018.

The end-user segments of the market are hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and services

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of seborrheic dermatitis and rising per capita healthcare expenditure. The seborrheic dermatitis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/seborrheic-dermatitis-treatment-market-8499

The European seborrheic dermatitis treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The seborrheic dermatitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of skin disorder and raising awareness about seborrheic dermatitis, the market in Asia-Pacific is expected to be the fastest-growing. The seborrheic dermatitis treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Rechercher
Catégories
Lire la suite
Fitness
Slim Zone Keto Gummies Customer Difference Benefits & Side Effects!
Slim Zone Gummies – Official Website Link – Click Here • Where to Get Bottle...
Par Emma Reid 2022-08-06 13:22:03 0 735
Party
台灣運彩足球讓分玩法,透過運彩分析找出最佳選擇
台灣運彩足球讓分是很多玩家都會選擇的投注玩法,新手玩家大多都會選擇猜測勝利隊伍的獨贏玩法,不過獨贏玩法的賠率較低,因此建議隊賽是足夠了解得玩家可以嘗試讓分玩法。...
Par 李 桂林 2024-06-26 09:03:33 0 68
Autre
Massey Ferguson 241 Tractor Price, Specifications, and Technological Features in 2023
The strong tractor Massey Ferguson 241 DI Maha Shakti features cutting-edge technology....
Par Sahubar Kha 2023-03-10 07:22:23 0 523
Networking
Mobile App Development Company
  In today’s fast-paced digital world, finding a reliable mobile app development...
Par Soundarya Vsm 2024-08-16 10:59:10 0 88
Networking
cats that dont shed
Discover a purr-fect world of feline wonders on our website. Explore expert insights, care tips,...
Par Fasih Ali123 2024-03-21 09:06:33 0 203